Cinacalcet |
|
| Synonyms: (aR)-a-Methyl-N-[3-[3-(trifluoromethyl)phenyl)propyl]-1-napthalenemethanamine;AMG 073 | |
| Cat. No.: C40000 | CAS No.: 226256-56-0 |
| MDL.: | Formula: C22H22F3N |
| F.W.357.41 | Purity: 99% |
| Storage: Refrigerator | |
|   | |
| Catalog Number: | C40000 | CAS No.: | 226256-56-0 | |
| MDL: | Formula: | C22H22F3N | ||
| F.W.: | 357.41 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | Yellow Oil | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Chloroform | Stability: | ||
| Storage: | Refrigerator | Category: | Reference Standard | |
| Reference: | Block, G, et al.: Am. J. Kidney Dis., 35, 1226 (2000), Moe, S., et al.: Am. J. Nephrol., 23, 369 (2003), Block, G., et al.: J. Am. Soc. Nephrol., 15, 2208 (2004). | |||
| Application: | Cinacalcet is the first calcimimetic drug approved by the United States Food and Drug Administration for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. | |||
| Category: | Chiral Reagents, Pharmaceuticals, Intermediates & Fine Chemicals, | |||








